Keros Therapeutics, Inc. (KROS) Stock price, Description, News & Info

#Thinksabio latest news

Keros Therapeutics Presents Additional Clinical Data from its KER-065 Program at the American Society of Bone and Mineral Research 2025 Annual Meeting